Chinese contract research organization (CRO) Biocytogen has raised a RMB543 million ($78 million) Series D round led by China Life Insurance and SDIC Venture Capital, a VC arm of the State Development & Investment Corporation (SDIC).
Existing investors CMB International – an investment arm of China Merchants Bank – Materia Medica Capital, and 3E Bioventures also participated in the funding round, according to a release. All three...
Culture Amp, an Australia-headquartered enterprise technology provider specializing in human resources (HR), has $100 million in Series F funding at a valuation of $1.5 billion.
SoftBank Ventures Asia has led a JPY6.2 billion ($56.4 million) Series C round for Japanese sneaker marketplace and e-commerce start-up Soda.
Suyi Kim, head of Asia Pacific at Canada Pension Plan Investment Board (CPPIB), has been named senior managing director and global head of private equity.
India-based automobile marketplace Droom has raised $200 million in the first tranche of a pre-IPO funding round that values the company at $1.2 billion.